Bethany Louise Mallino

Array ( [id] => 7672954 [patent_doc_number] => 20040180825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Semaphorin polypeptides' [patent_app_type] => new [patent_app_number] => 10/740773 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11040 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180825.pdf [firstpage_image] =>[orig_patent_app_number] => 10740773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921379 [patent_doc_number] => 20060240013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37)' [patent_app_type] => utility [patent_app_number] => 10/536049 [patent_app_country] => US [patent_app_date] => 2003-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31895 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240013.pdf [firstpage_image] =>[orig_patent_app_number] => 10536049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966407 [patent_doc_number] => 20050233304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Method of screening remedy for renal failure' [patent_app_type] => utility [patent_app_number] => 10/516517 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14950 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233304.pdf [firstpage_image] =>[orig_patent_app_number] => 10516517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584806 [patent_doc_number] => 07438913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Substances and their uses' [patent_app_type] => utility [patent_app_number] => 10/671697 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 12108 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/438/07438913.pdf [firstpage_image] =>[orig_patent_app_number] => 10671697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251985 [patent_doc_number] => 20050074777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Novel cell-surface estrogen receptor and related compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/665847 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18193 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074777.pdf [firstpage_image] =>[orig_patent_app_number] => 10665847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289127 [patent_doc_number] => 20040110127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Screening methods for identifying compounds which decrease HIV entry into a cell' [patent_app_type] => new [patent_app_number] => 10/661798 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11016 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110127.pdf [firstpage_image] =>[orig_patent_app_number] => 10661798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 482101 [patent_doc_number] => 07220546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Methods for diagnosing glaucoma and discovering anti-glaucoma drugs' [patent_app_type] => utility [patent_app_number] => 10/658986 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1482 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220546.pdf [firstpage_image] =>[orig_patent_app_number] => 10658986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 867790 [patent_doc_number] => 07364876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'ADIP protein and use thereof' [patent_app_type] => utility [patent_app_number] => 10/644084 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19102 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/364/07364876.pdf [firstpage_image] =>[orig_patent_app_number] => 10644084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465964 [patent_doc_number] => 20040101887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Methods of assaying receptor activity and constructs useful in such methods' [patent_app_type] => new [patent_app_number] => 10/628909 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11858 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101887.pdf [firstpage_image] =>[orig_patent_app_number] => 10628909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289286 [patent_doc_number] => 20040110189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/627273 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8921 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110189.pdf [firstpage_image] =>[orig_patent_app_number] => 10627273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7133519 [patent_doc_number] => 20040043023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Human glucocorticoid receptor 1A promoter and splice variants' [patent_app_type] => new [patent_app_number] => 10/620641 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13060 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043023.pdf [firstpage_image] =>[orig_patent_app_number] => 10620641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369292 [patent_doc_number] => 20040092716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Steroidogenic factor-1 protein variants and methods of making same' [patent_app_type] => new [patent_app_number] => 10/616897 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15080 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092716.pdf [firstpage_image] =>[orig_patent_app_number] => 10616897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289278 [patent_doc_number] => 20040110185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Human hypothalmic (\"HR\") receptor polypeptide compositions, methods and uses thereof' [patent_app_type] => new [patent_app_number] => 10/611210 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14355 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110185.pdf [firstpage_image] =>[orig_patent_app_number] => 10611210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674712 [patent_doc_number] => 20040127406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells' [patent_app_type] => new [patent_app_number] => 10/443732 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 95646 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127406.pdf [firstpage_image] =>[orig_patent_app_number] => 10443732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 501711 [patent_doc_number] => 07205398 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Eta-1 gene and methods for use' [patent_app_type] => utility [patent_app_number] => 10/443910 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 26373 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205398.pdf [firstpage_image] =>[orig_patent_app_number] => 10443910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664066 [patent_doc_number] => 20030203392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Screening method for SREBP pathway-specific inhibitors' [patent_app_type] => new [patent_app_number] => 10/436137 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6859 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203392.pdf [firstpage_image] =>[orig_patent_app_number] => 10436137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6731033 [patent_doc_number] => 20030187223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Secreted frizzled related protein,sFRP, fragments and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/425586 [patent_app_country] => US [patent_app_date] => 2003-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13362 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20030187223.pdf [firstpage_image] =>[orig_patent_app_number] => 10425586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635390 [patent_doc_number] => 20030211613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Methods of altering calcium transport' [patent_app_type] => new [patent_app_number] => 10/420637 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5928 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211613.pdf [firstpage_image] =>[orig_patent_app_number] => 10420637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679075 [patent_doc_number] => 20030229216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Constitutively activated human G protein coupled receptors' [patent_app_type] => new [patent_app_number] => 10/417820 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17400 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229216.pdf [firstpage_image] =>[orig_patent_app_number] => 10417820 [rel_patent_id] =>[rel_patent_doc_number] =>)